Showing results (191-200 of 378) with videos related to
Sort By:
Pageof 38
Frontiers in Plant Science|July 8, 2021
High-Density Linkage Map Construction and QTL Identification in a Diploid Blueberry Mapping PopulationXinpeng Qi, Elizabeth L Ogden, Hamed Bostan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 StudyErin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancerHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.The Journal of Thoracic and Cardiovascular Surgery|December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147Amanda I Phipps, Qian Shi, Polly A Newcomb, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigationShauna L Hillman, Ming-Wen An, Michael J O'Connell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Prognostic impact of bim, puma, and noxa expression in human colon carcinomasFrank A Sinicrope, Rafaela L Rego, Kenji Okumura, et al.Journal of the National Cancer Institute|July 11, 2015
Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer PatientsHarry H Yoon, Qian Shi, Steven R Alberts, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2015
Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung CancerNathan R Foster, Lindsay A Renfro, Steven E Schild, et al.Pageof 38